Key result
Baseline microalbuminuria independently predicted an increased risk of developing chronic renal insufficiency in hypertensive patients without diabetes.
Why the study?
Does microalbuminuria predict the development of chronic renal insufficiency and cardiovascular events in patients without diabetes and with primary hypertension?
Cohort (n=917)
Does microalbuminuria predict the development of chronic renal insufficiency and cardiovascular events in patients without diabetes and with primary hypertension?
Microalbuminuria is an independent predictor of long-term renal and cardiovascular complications in non-diabetic patients with primary hypertension.
Answers are grounded in this paper and cite their sources.
Suggests closer renal monitoring for non-diabetic hypertensives with microalbuminuria; hypothesis-generating and requires prospective confirmation before changing practice.
BACKGROUND AND OBJECTIVES: Increased urinary albumin excretion is a known risk factor for cardiovascular events and clinical nephropathy in patients with diabetes. Whether microalbuminuria predicts long-term development of chronic renal insufficiency (CRI) in patients without diabetes and with primary hypertension remains to be documented. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted an 11.8-year follow-up of 917 patients who did not have diabetes and had hypertension and were enrolled in the Microalbuminuria: A Genoa Investigation on Complications (MAGIC) cohort between 1993 and 1997. Urinary albumin-to-creatinine ratio (ACR) was assessed at baseline in untreated patients in a core laboratory. Microalbuminuria was defined as ACR > or =22 mg/g in men and ACR > or =31 mg/g in women. RESULTS: A total of 10,268 person-years of follow-up revealed that baseline microalbuminuria was associated with an increased risk for developing CRI (relative risk [RR] 7.61; 95% confidence interval [CI] 3.19 to 8.16; P < 0.0001), cardiovascular events (composite of fatal and nonfatal cardiac and cerebrovascular events; RR 2.11; 95% CI 1.08 to 4.13; P < 0.028), and cardiorenal events (composite of former end points; RR 3.21; 95% CI 1.86 to 5.53; P < 0.0001). Microalbuminuria remained significantly related to CRI (RR 12.75; 95% CI 3.62 to 44.92; P < 0.0001) and cardiorenal events (RR 2.58; 95% CI 1.32 to 5.05; P = 0.0056) even after adjustment for several baseline covariates. CONCLUSIONS: Microalbuminuria is an independent predictor of renal and cardiovascular complications in patients without diabetes and with primary hypertension.
No takes yet. Share an insight, caveat, or question.
Viazzi et al. (2010) conducted a cohort in Hypertension without diabetes (n=917). Microalbuminuria vs. No microalbuminuria was evaluated on Chronic renal insufficiency (CRI) (RR 12.75, 95% CI 3.62-44.92, p=<0.0001). Baseline microalbuminuria independently predicted an increased risk of developing chronic renal insufficiency in hypertensive patients without diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: